168 related articles for article (PubMed ID: 18785031)
1. Common variation in NOS1AP and KCNH2 genes and QT interval duration in young adults. The Cardiovascular Risk in Young Finns Study.
Raitakari OT; Blom-Nyholm J; Koskinen TA; Kähönen M; Viikari JS; Lehtimäki T
Ann Med; 2009; 41(2):144-51. PubMed ID: 18785031
[TBL] [Abstract][Full Text] [Related]
2. Common NOS1AP variants are associated with a prolonged QTc interval in the Rotterdam Study.
Aarnoudse AJ; Newton-Cheh C; de Bakker PI; Straus SM; Kors JA; Hofman A; Uitterlinden AG; Witteman JC; Stricker BH
Circulation; 2007 Jul; 116(1):10-6. PubMed ID: 17576865
[TBL] [Abstract][Full Text] [Related]
3. Relationship of common candidate gene variants to electrocardiographic T-wave peak to T-wave end interval and T-wave morphology parameters.
Porthan K; Marjamaa A; Viitasalo M; Väänänen H; Jula A; Toivonen L; Nieminen MS; Newton-Cheh C; Salomaa V; Kontula K; Oikarinen L
Heart Rhythm; 2010 Jul; 7(7):898-903. PubMed ID: 20215044
[TBL] [Abstract][Full Text] [Related]
4. KCNH2 polymorphism and methadone dosage interact to enhance QT duration.
Hajj A; Ksouda K; Peoc'h K; Curis E; Messali A; Deveaux LL; Bloch V; Prince N; Mouly S; Scherrmann JM; Lépine JP; Laplanche JL; Drici MD; Vorspan F
Drug Alcohol Depend; 2014 Aug; 141():34-8. PubMed ID: 24875677
[TBL] [Abstract][Full Text] [Related]
5. Common genetic variation in KCNH2 is associated with QT interval duration: the Framingham Heart Study.
Newton-Cheh C; Guo CY; Larson MG; Musone SL; Surti A; Camargo AL; Drake JA; Benjamin EJ; Levy D; D'Agostino RB; Hirschhorn JN; O'donnell CJ
Circulation; 2007 Sep; 116(10):1128-36. PubMed ID: 17709632
[TBL] [Abstract][Full Text] [Related]
6. Common candidate gene variants are associated with QT interval duration in the general population.
Marjamaa A; Newton-Cheh C; Porthan K; Reunanen A; Lahermo P; Väänänen H; Jula A; Karanko H; Swan H; Toivonen L; Nieminen MS; Viitasalo M; Peltonen L; Oikarinen L; Palotie A; Kontula K; Salomaa V
J Intern Med; 2009 Apr; 265(4):448-58. PubMed ID: 19019189
[TBL] [Abstract][Full Text] [Related]
7. Analysis for Genetic Modifiers of Disease Severity in Patients With Long-QT Syndrome Type 2.
Kolder ICRM; Tanck MWT; Postema PG; Barc J; Sinner MF; Zumhagen S; Husemann A; Stallmeyer B; Koopmann TT; Hofman N; Pfeufer A; Lichtner P; Meitinger T; Beckmann BM; Myerburg RJ; Bishopric NH; Roden DM; Kääb S; Wilde AAM; Schott JJ; Schulze-Bahr E; Bezzina CR
Circ Cardiovasc Genet; 2015 Jun; 8(3):447-456. PubMed ID: 25737393
[TBL] [Abstract][Full Text] [Related]
8. A common variant of NOS1AP is associated with QT interval duration in a Chinese population with Type 2 diabetes.
Lu J; Hu C; Hu W; Zhang R; Wang C; Qin W; Yu W; Xiang K; ; Jia W
Diabet Med; 2010 Sep; 27(9):1074-9. PubMed ID: 20722683
[TBL] [Abstract][Full Text] [Related]
9. Gender and effects of a common genetic variant in the NOS1 regulator NOS1AP on cardiac repolarization in 3761 individuals from two independent populations.
Tobin MD; Kähönen M; Braund P; Nieminen T; Hajat C; Tomaszewski M; Viik J; Lehtinen R; Ng GA; Macfarlane PW; Burton PR; Lehtimäki T; Samani NJ
Int J Epidemiol; 2008 Oct; 37(5):1132-41. PubMed ID: 18511491
[TBL] [Abstract][Full Text] [Related]
10. Calcium channel blockers, NOS1AP, and heart-rate-corrected QT prolongation.
van Noord C; Aarnoudse AJ; Eijgelsheim M; Sturkenboom MC; Straus SM; Hofman A; Kors JA; Newton-Cheh C; Witteman JC; Stricker BH
Pharmacogenet Genomics; 2009 Apr; 19(4):260-6. PubMed ID: 19247217
[TBL] [Abstract][Full Text] [Related]
11. Association of NOS1AP genetic variants with QT interval duration in families from the Diabetes Heart Study.
Lehtinen AB; Newton-Cheh C; Ziegler JT; Langefeld CD; Freedman BI; Daniel KR; Herrington DM; Bowden DW
Diabetes; 2008 Apr; 57(4):1108-14. PubMed ID: 18235038
[TBL] [Abstract][Full Text] [Related]
12. Potassium channel KCNH2 K897T polymorphism and cardiac repolarization during exercise test: The Finnish Cardiovascular Study.
Koskela J; Laiho J; KäHönen M; Rontu R; Lehtinen R; Viik J; Niemi M; Niemelä K; Kööbi T; Turjanmaa V; Pörsti I; Lehtimäki T; Nieminen T
Scand J Clin Lab Invest; 2008; 68(1):31-8. PubMed ID: 17852802
[TBL] [Abstract][Full Text] [Related]
13. Association of KCNQ1, KCNE1, KCNH2 and SCN5A polymorphisms with QTc interval length in a healthy population.
Gouas L; Nicaud V; Berthet M; Forhan A; Tiret L; Balkau B; Guicheney P;
Eur J Hum Genet; 2005 Nov; 13(11):1213-22. PubMed ID: 16132053
[TBL] [Abstract][Full Text] [Related]
14. Functional significance of KCNH2 (HERG) K897T polymorphism for cardiac repolarization assessed by analysis of T-wave morphology.
Linna EH; Perkiömäki JS; Karsikas M; Seppänen T; Savolainen M; Kesäniemi YA; Mäkikallio T; Huikuri HV
Ann Noninvasive Electrocardiol; 2006 Jan; 11(1):57-62. PubMed ID: 16472284
[TBL] [Abstract][Full Text] [Related]
15. Association of rs10918594 polymorphisms of nitric oxide synthase 1 adaptor protein (NOS1AP) with QTc interval prolongation during kidney transplantation.
Kaczmarczyk M; Biernawska J; Zukowski M; Kotfis K; Zegan-Barańska M; Bińczak-Kuleta A; Ciechanowicz A; Brykczyński M; Bohatyrewicz R
Transplant Proc; 2011 Oct; 43(8):2964-6. PubMed ID: 21996201
[TBL] [Abstract][Full Text] [Related]
16. Sex is a moderator of the association between NOS1AP sequence variants and QTc in two long QT syndrome founder populations: a pedigree-based measured genotype association analysis.
Winbo A; Stattin EL; Westin IM; Norberg A; Persson J; Jensen SM; Rydberg A
BMC Med Genet; 2017 Jul; 18(1):74. PubMed ID: 28720088
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms in the NOS1AP gene modulate QT interval duration and risk of arrhythmias in the long QT syndrome.
Tomás M; Napolitano C; De Giuli L; Bloise R; Subirana I; Malovini A; Bellazzi R; Arking DE; Marban E; Chakravarti A; Spooner PM; Priori SG
J Am Coll Cardiol; 2010 Jun; 55(24):2745-52. PubMed ID: 20538168
[TBL] [Abstract][Full Text] [Related]
18. NOS1AP Polymorphisms Modify QTc Interval Duration But Not Cardiac Arrest Risk in Hypertrophic Cardiomyopathy.
Earle N; Ingles J; Bagnall RD; Gray B; Crawford J; Smith W; Shelling AN; Love DR; Semsarian C; Skinner JR
J Cardiovasc Electrophysiol; 2015 Dec; 26(12):1346-51. PubMed ID: 26332198
[TBL] [Abstract][Full Text] [Related]
19. Protective effect of KCNH2 single nucleotide polymorphism K897T in LQTS families and identification of novel KCNQ1 and KCNH2 mutations.
Zhang X; Chen S; Zhang L; Liu M; Redfearn S; Bryant RM; Oberti C; Vincent GM; Wang QK
BMC Med Genet; 2008 Sep; 9():87. PubMed ID: 18808722
[TBL] [Abstract][Full Text] [Related]
20. KCNH2-K897T is a genetic modifier of latent congenital long-QT syndrome.
Crotti L; Lundquist AL; Insolia R; Pedrazzini M; Ferrandi C; De Ferrari GM; Vicentini A; Yang P; Roden DM; George AL; Schwartz PJ
Circulation; 2005 Aug; 112(9):1251-8. PubMed ID: 16116052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
